Although the precise mechanisms involved in the onset of MAS are not well known, there is evidence to support the role of IL-18 in IFN-γ release, and elevated IL-18 levels may explain the link between hyperactivity of the inflammasome and secondary HLH/MAS. The gene discussed is IFNG; the disease is macrophage activation syndrome.